General practitioners (GPs) in the UK have long had direct access to hospital radiological services, which in theory shortens investigation time and improves the quality of service. Chest X-rays (CXRs) account for a substantial proportion of requests, and we investigated what happened when an abnormality was detected.
INTRODUCTION
Direct access to hospital radiological services was first made available to general practitioners (GPs) in the UK over 30 years agol. The value of this service was emphasized by a joint working party of the Royal College of General Practitioners and the Royal College of Radiologists in 1981; it shortens investigation time, improves the quality of service offered by GPs and increases the interest of their work2. Since then, selection guidelines have been published by the Royal College of Radiologists to help doctors make the best use of these services and have been shown to be useful3'4.
Chest radiographs (CXR) comprise 36-58% of all radiological requests made by GPs5'6. Previous studies in this area have audited the referral pattern of GPs requesting CXRs with the aim of producing guidelines to help GPs select patients likely to have abnormal CXRs7'8. However, no study has examined what happens to patients once an abnormality is detected.
The present practice in most UK hospitals is for a copy of the CXR report to be returned to the requesting GP who retains overall responsibility for further referral of the patient as necessary2. However, there is concern that, in some patients with abnormal CXRs, there is a delay in diagnosis due to loss or delay in follow-up. We therefore conducted a retrospective study of patients referred by GPs for a CXR to determine the need for and adequacy of follow-up in these patients.
METHOD
The Nottingham City Hospital radiology department records were examined for reports of CXRs requested by GPs from 1 April 1996 to 30 April 1996 inclusive. All reports were reviewed by three respiratory physicians (WSL, PD, DRB) and classified into three categories according to the perceived need for repeat X-ray or respiratory physician referral ('hospital follow-up'): (A) normal film or an abnormality noted that was unchanged from previous films; (B) new abnormality noted but no hospital follow-up indicated; and (C) a new abnormality noted and hospital follow-up indicated.
Hospital records of patients in group C were then examined to determine whether they were seen at either the Nottingham City Hospital or the University Hospital, Nottingham, in the three months following the initial CXR. The time from initial CXR to hospital follow-up and the final diagnosis were recorded. The GP who ordered the CXR was contacted to determine the outcome of patients not referred to hospital. Patients seen in hospital more than three months after the initial CXR were considered to have consulted for a separate event unless reasons for a delay in follow-up were specifically recorded. (Table 1) . Follow-up data were available for 70 (99%) patients. One patient had moved out of the area and was lost to follow-up. 64 (91%) of the 70 patients were seen in hospital within 3 months of the initial CXR (Table 2 ). 6 patients were never referred by their GPs for follow-up evaluation. In 5 patients the CXR changes were consistent with infection and an active decision had been made by the GP not to refer; all made a good recovery. In one patient, follow-up was recommended because of a distorted breast shadow suspicious of malignancy on CXR; this patient was not referred by her GP as she had a well-documented history of breast cancer with previous surgery, which had not been made known to the reporting radiologist.
Mass lesion on CXR
In the 27 patients with a mass lesion suspicious of tumour on CXR, the median time to follow-up was 20 days (range 0-83). Cancer was diagnosed in 18 (67%) patients (Table 3) . These were all previously undiagnosed malignancies. GP referral letters were available for review in 19 (70%) of the 27 cases. The median time from initial CXR to GP referral as reflected in the date recorded on the referral letter was 13 days (range 0-21) with 47% of referrals made within 7 days.
Infective shadowing on CXR In 35 patients, follow-up was recommended following a CXR consistent with infection. The usual recommendation in these cases is for a repeat film in four to six weeks to document resolution of the CXR changes after appropriate treatment. One patient was lost to follow-up. The median time to follow-up for the remaining 34 patients was 35 days (range 0-87). An underlying malignancy was diagnosed at follow-up in 3 patients, all over 60 years of age. One was a current cigarette smoker and another an ex-pipe-smoker.
Smoking status was not recorded in the remaining patient.
DISCUSSION
Our data confirm that GPs do act on reports of abnormal CXRs. However, there is a substantial delay even when a lesion suggestive of cancer is reported. The British Thoracic Society (BTS) and the Standing Medical Advisory Committee have both published recommendations detailing standards of care in lung cancer9 10. Studies that have evaluated lung cancer services in the light of these recommendations have revealed delays in patient referral and assessment11 '3 We have shown that only 37% of patients with a mass suspicious of cancer on CXR are seen in a respiratory clinic within two weeks of the X-ray as recommended by the BTS. Potential sources of delay include delays in (a), patients attending for examination, (b) CXR reporting, (c) receipt of CXR reports by GPs and (d) response by GPs to abnormal reports. Doubtless these factors contribute in varying degrees in individual cases. However, even small delays occurring at each stage of assessment, investigation and treatment contribute to the much larger overall delay seen in many instances. Billing and Wells reported a mean total delay of about three months from patient presentation to operation for lung cancer, resulting from delays accrued at each stage of investigation13. Any strategy aimed at reducing overall delay in lung cancer management must therefore address each of these smaller delays.
Barriers to a prompt and appropriate response to abnormal CXRs include issues of resources, clinical responsibilities and local choices. The Calman-Hine report proposed primary care as the focus of cancer service care and that the relationship between primary care and the hospital should be one of partnership in continuing care rather than permanent or temporary transfer of responsibility for the patient. It also proposed that local guidelines for the identification and management of symptoms suggestive of malignancy should be established. These should be flexible yet adhere to nationally agreed and rigorously evaluated standards14.
We feel that one approach to reducing delay that embraces these concepts might be for GPs to allow direct referral from the radiology department to respiratory physicians for patients with suspicious CXRs. Many GPs might welcome such a service if they knew in advance of this facility and were able to indicate on the CXR referral card their intention either to transfer or to retain clinical responsibility. This flexibility would allow GPs to remain directly involved with the diagnostic process and be in a position to provide psychological and emotional support as required.
Waiting for referral and diagnosis in the knowledge that the CXR is abnormal is stressful for patients and family15. In the new white paper, the government announced its commitment to the improvement of access to specialist services for people with suspected cancer. Linking GPs' direct access to radiological services to hospital specialist services may be a reasonable way forward. If we are to provide better cancer care, such processes will need to be developed and tested.
